| Name | 2-bromo-N-(1,2-oxazol-3-yl)acetamide |
|---|---|
| Synonyms |
Acetamide,2-bromo-N-3-isoxazolyl
2-bromo-N-isoxazol-3-ylacetamide |
| Molecular Formula | C5H5BrN2O2 |
|---|---|
| Molecular Weight | 205.00900 |
| Exact Mass | 203.95300 |
| PSA | 58.36000 |
| LogP | 0.42990 |
|
~79%
92931-33-4 |
| Literature: RVX Therapeutics Inc.; McLure, Kevin G.; Young, Peter R. Patent: US2013/281398 A1, 2013 ; Location in patent: Paragraph 0556; 0557 ; |
|
~%
92931-33-4 |
| Literature: NOVARTIS AG; NOVARTIS PHARMA GMBH Patent: WO2004/96800 A2, 2004 ; Location in patent: Page 76 ; WO 2004/096800 A2 |
|
~%
92931-33-4 |
| Literature: Bull, Richard James; Skidmore, Elizabeth Anne; Ford, Rhonan Lee; Mather, Andrew Nigel; Mete, Antonio Patent: US2011/172237 A1, 2011 ; Location in patent: Page/Page column 20 ; |